Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease

Pediatrics International

Volumn 47, Issue 3, 2005, Pages 305-310

  Takahashi, Kei ^a   Oharaseki, Toshiaki ^a   Naoe, Shiro ^a   Wakayama, Megumi ^a   Yokouchi, Yuki ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary arteritis; Coronary artery aneurysm; Immunohistochemistry; Kawasaki disease; Neutrophil elastase

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; EOSIN; HEMATOXYLIN; IMMUNOGLOBULIN; LEUKOCYTE ELASTASE; PARAFFIN;

ARTERY LESION; ARTICLE; AUTOPSY; B LYMPHOCYTE; CAUSE OF DEATH; CORONARY ARTERY; DISEASE DURATION; HEART INFARCTION; HEART TAMPONADE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INFLAMMATORY CELL; MACROPHAGE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; PRIORITY JOURNAL; T LYMPHOCYTE; VASODILATATION;

ACUTE DISEASE; CHILD, PRESCHOOL; CORONARY VESSELS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MACROPHAGES; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL ACTIVATION; NEUTROPHILS; TIME FACTORS;

EID: 20444503366     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-200x.2005.02049.x     Document Type: Article

References (18)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of fingers and toes in children. Clinical observation of 50 patients. Jpn. J. Allergy 1967; 16: 178-222.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph-node syndrome (MLNS) prevailing in Japan. Pediatrics 1974; 54: 271-6.
3. Yanagawa H, Nakamura Y, Yashiro M et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001; 107: E33.
4. Nakano M, Yamada S, Hayashi Y, Morishita M, Iwaki T, Toyoda M. Preventive effects of ulinastatin for coronary artery aneurysm formation in Kawasaki disease. In: Kato H (ed.). Kawasaki Disease. Elsevier Science, Amsterdam, 1995; 364-71.
5. Takeshita S, Nakatani K, Kawase H et al. The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. J. Infect. Dis. 1999; 179: 508-12.
6. Takeshita S, Sekine I, Fujisawa T, Yoshioka S. Studies of peripheral blood toxic neutrophils as a predictor of coronary risk in Kawasaki disease: the pathogenic role of hematopoietic colony-stimulating factors (GM-SF, G-GSF). Acta Paediatr. Jpn. 1990; 32: 508-14.
7. Suzuki H, Noda E, Miyawaki M, Takeuchi T, Uemura S, Koike M. Serum levels of neutrophil activation cytokines in Kawasaki disease. Pediatr. Int. 2001; 43: 115-19.
8. Smedly LA, Tonnesen MG, Sandhaus RA et al. Neutrophil-mediated injury to endothelial cells. Enhancement by endotoxin and essential role of neutrophil elastase. J. Clin. Invest. 1986; 77: 1233-43.
9. Inoue Y, Kato M, Kobayashi T, Shinohara M, Sone K, Morikawa A. Increased circulating granulocyte colony-stimulating factor in acute Kawasaki diease. Pediatr. Int. 1999; 41: 330-3.
10. Naoe S, Takahashi K, Masuda H, Tanaka N. Kawasaki disease with particular emphasis on arterial lesions. Acta Pathol. Jpn. 1991; 41: 785-97.
11. Landing HL, Larson E. Pathological features of Kawasaki disease (mucocutaneous lymph node syndrome). Am. J. Cardiovasc. Pathol. 1987; 1: 215-29.
12. Terai M, Kohno Y, Niwa K, Toba T, Sakurai N, Nakajima H. Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am. J. Cardiol. 1987; 60: 555-9.
13. Rowley AH, Shulman ST, Mask CA et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney and coronary artery in acute Kawasaki disease. J. Infect. Dis. 2000; 182: 1183-91.
14. Masuda H, Naoe S, Tanaka N. A pathological study of coronary artery in Kawasaki disease (MCLS): with special reference to morphogenesis of aneurysm. J. Jpn. Coll. Angiol. 1981; 21: 899-912.
15. Newburger JW, Takahashi M, Burns JC et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 1986; 315: 341-7.
16. Nakatani K, Takeshita S, Tsujimoto H, Kawamura Y, Kawase H, Sekine I. Regulation of the expression of Fc-gamma receptor on circulating neutrophils and monocytes in Kawasaki disease. Clin. Exp. Immunol. 1999; 117: 418-22.
17. Zaitsu M, Hamasaki Y, Tashiro K et al. Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type2 in Kawasaki disease. J. Infect. Dis. 2000; 181: 1101-9.
18. Okada M, Nakai S, Kobayashi Y, Satoh T. Effects of intravenous gamma globulin and ulinastatin on patients with Kawasaki disease and predicted giant coronary artery aneurysms. J. Jpn. Pediatr. Soc. 1997; 101: 1165-70.